PVI
TEVA icon

Pura Vida Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Pura Vida Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-124,875
Closed -$4.01M – 89
2017
Q1 		$4.01M Buy
+124,875
New +$4.26M 1.19% 43
2015
Q2 		– Sell
-33,650
Closed -$2.1M – 82
2015
Q1 		$2.1M Buy
33,650
+2,150
+7% +$125K 1.08% 37
2014
Q4 		$1.81M Buy
+31,500
New +$1.75M 0.67% 52

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pura Vida Investments's TEVA Position: Q2 2017 in Review

Pura Vida Investments sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 124,875 shares — an estimated $4.01M sold.

Pura Vida Investments first reported a position in TEVA in Q4 2014 and held it in 3 quarters. The position peaked at $4.01M in Q1 2017. 649 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Pura Vida Investments reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Pura Vida Investments sold 124,875 Teva Pharmaceuticals shares in Q2 2017, an estimated $4.01M.
  • Pura Vida Investments first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 3 quarters.
  • Pura Vida Investments's Teva Pharmaceuticals position peaked at $4.01M in Q1 2017.
  • 649 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Pura Vida Investments's 13F filing for Q2 2017, filed 14 Aug 2017.